Aim of this study was to genetically characterize two carbapenemase-producing Escherichia coli strains obtained from a pediatric patient affected by diarrhea, expressing OXA-181 and/or NDM-5 type enzymes. The above microorganisms were collected in the same Desenzano hospital (Northern Italy) where the bla NDM- 5 gene was detected for the first time in Italy 3 years ago. One strain (5P), belonged to sequence type ST405/ST477 (according to Pasture/Oxford schemes) and serotype O102:H6. It was characterized by a 130562 bp multi-replicon plasmid IncFII/IncFIA/IncFIB (pVSI_NDM-5) enclosing two main antibiotic resistance islands: (i) ARI-I, 10030 bp in size, carried genes coding for β-lactam- (bla OXA- 1, bla CTX-M- 15), fluoroquinolone/aminoglycoside- (aac(6')-lb-cr) and phenicol- resistance (catB3), (ii) ARI-II, 15326 bp in size, carried genes coding for sulfonamide- (sul1), β-lactam- (bla NDM- 5, bla TEM- 1 B), phenicol- (catB3), trimethoprim- (dfrA17), antiseptic- (qacEΔ1), and aminoglycoside- (aadA5, rmtB) resistance. The other isolate (5M), belonged to sequence type ST2659/ST759 and serotype O50/02:H18, and carried four plasmids: a 153866 bp multi-replicon IncFII/IncFIA/IncFIB (pISV_IncFII_NDM-5), an 89866 bp IncI1 plasmid, a 51480 bp IncX3 plasmid (pISV_IncX3_OXA181), and a 41143 bp IncI plasmid (pISV_IncI_CMY-42). pISV_IncFII_NDM-5 carried two main antibiotic resistance islands: (i) ARI-III, 12220 bp in size, carried genes coding for β-lactam- (bla OXA- 1), fluoroquinolone/aminoglycoside- (aac(6')-lb-cr), tetracycline- (tet(B)) and phenicol- resistance (catB3, catA1), and ii) ARI-IV, 26527 bp in size, carried determinants coding for macrolide- (erm(B), mph(A)), sulfonamide- (sul1), beta-lactam- (bla NDM- 5, bla TEM- 1 B), trimethoprim- (dfrA14, dfrA12), antiseptic- (qacEΔ1), and aminoglycoside- resistance (aadA5). pISV_IncI_CMY-42 harbored the bla CMY- 42 gene coding for beta-lactam resistance, pISV_IncX3_OXA181 harbored genes encoding fluoroquinolone- (qnrS1) and beta-lactams- resistance (bla OXA- 181). In conclusion, the detection of two different NDM-5 E. coli strains from a pediatric patient with a history of travel to the Far East countries strongly highlight an increasing trend and risk of importation from such areas.

Biomedical Center Faculty of Medicine in Pilsen Charles University Pilsen Czechia

Clinical Microbiology Laboratory AO Desenzano del Garda Brescia Italy

Department of Clinical Surgical Diagnostic and Pediatric Sciences Unit of Microbiology and Clinical Microbiology University of Pavia Pavia Italy

Department of Microbiology Faculty of Medicine in Pilsen University Hospital in Pilsen Charles University Pilsen Czechia

Zobrazit více v PubMed

Aung M. S., San N., Maw W. W., San T., Urushibara N., Kawaguchiya M., et al. (2018). Prevalence of extended-spectrum Beta-Lactamase and carbapenemase genes in clinical isolates of PubMed DOI

Baek J. Y., Cho S. Y., Kim S. H., Kang C.-I., Peck K. R., Song J.-H., et al. (2019). Plasmid analysis of PubMed DOI

Balm M. N. D., Ngan G., Jureen R., Lin R. T. P., Teo J. W. P. (2013). OXA-181-producing PubMed DOI PMC

Barton B., Harding G., Zuccarelli A. (1995). A general method for detecting and sizing large plasmids. PubMed DOI

Bitar I., Dagher C., Salloum T., Araj G., Tokajian S. (2018). First report of an PubMed DOI

Bitar I., Piazza A., Gaiarsa S., Villa L., Pedroni P., Oliva E., et al. (2017). ST405 NDM-5 producing PubMed DOI

Brettin T., Davis J. J., Disz T., Edwards R. A., Gerdes S., Olsen G. J., et al. (2015). RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. PubMed DOI PMC

Camacho C., Coulouris G., Avagyan V., Ma N., Papadopoulos J., Bealer K., et al. (2009). BLAST+: architecture and applications. PubMed DOI PMC

Carattoli A., Zankari E., García-Fernández A., Larsen M. V., Lund O., Villa L., et al. (2014). In SilicoDetection and typing of plasmids using plasmidfinder and plasmid multilocus sequence typing. PubMed DOI PMC

Castanheira M., Deshpande L. M., Mathai D., Bell J. M., Jones R. N., Mendes R. E. (2010). Early dissemination of NDM-1- and OXA-181-producing PubMed DOI PMC

Cho S. Y., Huh H. J., Baek J. Y., Chung N. Y., Ryu J. G., Ki C.-S., et al. (2015). PubMed DOI PMC

Dagher T. N., Azar E., Al-Bayssari C., Chamieh A. S., Rolain J.-M. (2019). First detection of colistin-resistant PubMed DOI

Djordjevic S. P., Roy Chowdhury P., McKinnon J. M., Liu M. Y. (2018). Multidrug resistant uropathogenic PubMed DOI PMC

Doi Y., Potoski B. A., Adams-Haduch J. M., Sidjabat H. E., Pasculle A. W., Paterson D. L. (2008). Simple disk-based method for detection of PubMed DOI PMC

Glupczynski Y., Huang T.-D., Bouchahrouf W., Castro R. R. D., Bauraing C., Gérard M., et al. (2012). Rapid emergence and spread of OXA-48-producing carbapenem-resistant PubMed DOI

Hoang C. Q., Nguyen H. D., Vu H. Q., Nguyen A. T., Pham B. T., Tran T. L., et al. (2019). Emergence of New Delhi Metallo-Beta-Lactamase (NDM) and PubMed DOI PMC

Hornsey M., Phee L., Wareham D. W. (2011). A novel variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant PubMed DOI PMC

Jeon J., Lee J., Lee J., Park K., Karim A., Lee C.-R., et al. (2015). Structural basis for Carbapenem-hydrolyzing mechanisms of Carbapenemases conferring antibiotic resistance. PubMed DOI PMC

Joensen K. G., Scheutz F., Lund O., Hasman H., Kaas R. S., Nielsen E. M., et al. (2014). Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic PubMed DOI PMC

Kamjumphol W., Wongboot W., Suebwongsa N., Kluabwang P., Chantaroj S., Okada K. (2019). Draft genome sequence of a colistin-resistant PubMed DOI

Larsen M. V., Cosentino S., Rasmussen S., Friis C., Hasman H., Marvig R. L., et al. (2012). Multilocus sequence typing of total-genome-sequenced bacteria. PubMed DOI PMC

Lee K., Lim Y. S., Yong D., Yum J. H., Chong Y. (2003). Evaluation of the hodge test and the imipenem-EDTA double-disk synergy test for differentiating Metallo- -Lactamase-producing isolates of PubMed DOI PMC

Mairi A., Pantel A., Sotto A., Lavigne J.-P., Touati A. (2017). OXA-48-like carbapenemases producing PubMed DOI

Mediavilla J. R., Patrawalla A., Chen L., Chavda K. D., Mathema B., Vinnard C., et al. (2016). Colistin- and carbapenem-resistant PubMed DOI PMC

Monaco F., Mento G. D., Cuscino N., Conaldi P., Douradinha B. (2018). Infant colonisation with PubMed DOI

Nakano R., Nakano A., Hikosaka K., Kawakami S., Matsunaga N., Asahara M., et al. (2014). First Report of Metallo-β-Lactamase NDM-5-Producing PubMed DOI PMC

Nordmann P., Poirel L., Walsh T. R., Livermore D. M. (2011). The emerging NDM carbapenemases. PubMed DOI

Ortega A., Sáez D., Bautista V., Fernández-Romero S., Lara N., Aracil B., et al. (2016). Carbapenemase-producing PubMed DOI

Park M., Park S. D., Lee M. H., Kim S.-H., Lim K., Lee G., et al. (2016). The first report of NDM-5–producing uropathogenic PubMed DOI

Paskova V., Medvecky M., Skalova A., Chudejova K., Bitar I., Jakubu V., et al. (2018). Characterization of NDM-encoding plasmids from PubMed DOI PMC

Piazza A., Comandatore F., Romeri F., Pagani C., Floriano A. M., Ridolfo A., et al. (2018). First report of an ST410 OXA-181 and CTX-M-15 coproducing PubMed DOI

Pitart C., Solé M., Roca I., Román A., Moreno A., Vila J., et al. (2015). Molecular characterization ofblaNDM-5carried on an IncFII plasmid in an PubMed DOI PMC

Poirel L., Heritier C., Tolun V., Nordmann P. (2004). Emergence of oxacillinase-mediated resistance to imipenem in PubMed DOI PMC

Poirel L., Potron A., Nordmann P. (2012). OXA-48-like carbapenemases: the phantom menace. PubMed DOI

Rojas L. J., Hujer A. M., Rudin S. D., Wright M. S., Domitrovic T. N., Marshall S. H., et al. (2017). NDM-5 and OXA-181 Beta-Lactamases, a significant threat continues to spread in the Americas. PubMed DOI PMC

Rotova V., Papagiannitsis C. C., Skalova A., Chudejova K., Hrabak J. (2017). Comparison of imipenem and meropenem antibiotics for the MALDI-TOF MS detection of carbapenemase activity. PubMed DOI

Sassi A., Loucif L., Gupta S. K., Dekhil M., Chettibi H., Rolain J.-M. (2014). NDM-5 Carbapenemase-encoding gene in multidrug-resistant clinical isolates of PubMed DOI PMC

Shen Z., Hu Y., Sun Q., Hu F., Zhou H., Shu L., et al. (2018). Emerging carriage of NDM-5 and MCR-1 in PubMed DOI PMC

Solgi H., Badmasti F., Aminzadeh Z., Giske C. G., Pourahmad M., Vaziri F., et al. (2017). Molecular characterization of intestinal carriage of carbapenem-resistant PubMed DOI

Sugawara Y., Akeda Y., Hagiya H., Sakamoto N., Takeuchi D., Shanmugakani R. K., et al. (2019). Spreading patterns of NDM-producing PubMed DOI PMC

Sugawara Y., Akeda Y., Sakamoto N., Takeuchi D., Motooka D., Nakamura S., et al. (2017). Genetic characterization of blaNDM-harboring plasmids in carbapenem-resistant PubMed DOI PMC

Wu W., Feng Y., Tang G., Qiao F., Mcnally A., Zong Z. (2019). NDM Metallo-β-Lactamases and their bacterial producers in health care settings. PubMed DOI PMC

Yaici L., Haenni M., Saras E., Boudehouche W., Touati A., Madec J.-Y. (2016). blaNDM-5-carrying IncX3 plasmid in PubMed DOI

Yang Q., Fang L., Fu Y., Du X., Shen Y., Yu Y. (2015). Dissemination of NDM-1-producing PubMed DOI PMC

Zankari E., Hasman H., Cosentino S., Vestergaard M., Rasmussen S., Lund O., et al. (2012). Identification of acquired antimicrobial resistance genes. PubMed DOI PMC

Preferred β-lactone synthesis can explain high rate of false-negative results in the detection of OXA-48-like carbapenemases

Genetic Plurality of OXA/NDM-Encoding Features Characterized From Enterobacterales Recovered From Czech Hospitals

Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy